Media
|
Contact
|
Disclaimer
|
Careers
About us
Vision & Mission
Goal & Strategy
Values
Board of Directors
Management
Business Development
Oncology
Cancer at a glance
Belinostat
Mode of action
Clinical use
Safety profile
Indications and clinical program
Belinostat clinical studies
NCI- and Investigator Sponsored Trials
Belinostat abstracts - ASCO 2013
Science
Histone Deacetylase (HDAC)
Scientific publications
Glossary
Collaborators
Academic collaborators
Partners
Investor
About us
Vision & Mission
Goal & Strategy
Values
Board of Directors
Management
Anders Fink Vadsholt
Elisabeth V. Carstensen
Anne V. Sillemann
Jette Tjørnelund
Lone Dahl
Business Development
Management
Anders Fink Vadsholt
Chief Executive Officer
Elisabeth V. Carstensen
Director of Pharmaceutical Operations
Anne V. Sillemann
Director of Global Regulatory Affairs
Jette Tjørnelund
Director of Science
Lone Dahl
Director of Finance